(Q38059092)

27 August 2017

Potassium channels: a review of broadening therapeutic possibilities for neurological diseases (English)

1 reference

27 August 2017

Snezana Maljevic

1

1 reference

27 August 2017

Holger Lerche

series ordinal

2

1 reference

27 August 2017

11 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

260

1 reference

27 August 2017

9

1 reference

27 August 2017

2201-2211

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-012-6727-8

27 August 2017

0 references

cites work

Molecular diversity of K+ channels

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

The Structure of the Potassium Channel: Molecular Basis of K+ Conduction and Selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Crystal structure of a mammalian voltage-dependent Shaker family K+ channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Inwardly rectifying potassium channels: their structure, function, and physiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

The pore structure and gating mechanism of K2P channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Localization and targeting of voltage-dependent ion channels in mammalian central neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Nervous system KV7 disorders: breakdown of a subthreshold brake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Pre- and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Neuronal trafficking of voltage-gated potassium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Determinants of voltage-gated potassium channel surface expression and localization in Mammalian neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Episodic ataxia type 1: a neuronal potassium channelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

21 January 2018

12 December 2020

A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Neuronal KCNQ potassium channels: physiology and role in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Neural KCNQ (Kv7) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

A potassium channel mutation in neonatal human epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Subthreshold changes of voltage-dependent activation of the K(V)7.2 channel in neonatal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Neutralization of a negative charge in the S1-S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Idiopathic epilepsy and paroxysmal dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Early-onset absence epilepsy and paroxysmal dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Acquired dendritic channelopathy in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

KATP channel openers: structure-activity relationships and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Ion channel pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Potassium channels: possible new therapeutic targets in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Modulators of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels and their Therapeutic Indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Inhibition of large-conductance calcium-activated potassium channel by 2-methoxyestradiol in cultured vascular endothelial (HUV-EC-C) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Activation by zonisamide, a newer antiepileptic drug, of large-conductance calcium-activated potassium channel in differentiated hippocampal neuron-derived H19-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Estradiol binding to maxi-K channels induces their down-regulation via proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

BK channel modulators: a comprehensive overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Slack and Slick K(Na) channels regulate the accuracy of timing of auditory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

The SLO3 sperm-specific potassium channel plays a vital role in male fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Voltage-gated potassium channels as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Novel anticonvulsant drugs targeting voltage-dependent ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Refinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6727-8

Therapeutic potential of neuronal two-pore domain potassium-channel modulators

21 January 2018

1 reference

12 December 2020

Potassium channels: molecular defects, diseases, and therapeutic opportunities.

1 reference

12 December 2020

Voltage-gated ion channels and hereditary disease

1 reference

12 December 2020

Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels

1 reference

12 December 2020

Drugs for preventing red blood cell dehydration in people with sickle cell disease

1 reference

12 December 2020

Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.

1 reference

12 December 2020

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

1 reference

12 December 2020

Diazoxide concentration-response relation in hypertension

1 reference

12 December 2020

Treatment for Lambert-Eaton myasthenic syndrome

1 reference

12 December 2020

Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine

1 reference

12 December 2020

10.1007/S00415-012-6727-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1024850987

0 references

Fatcat ID

release_ngymdb5mivgitcqsj72jbizbqq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ngymdb5mivgitcqsj72jbizbqq

24 November 2022

mapped directly with Wikidata item

1 reference